167 related articles for article (PubMed ID: 38509882)
21. Drug-drug interactions between COVID-19 therapeutics and psychotropic medications.
Cuomo A; Barillà G; Serafini G; Aguglia A; Amerio A; Cattolico M; Carmellini P; Spiti A; Fagiolini A
Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):925-936. PubMed ID: 38032183
[TBL] [Abstract][Full Text] [Related]
22. Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study.
Tagwerker C; Carias-Marines MJ; Smith DJ
JMIRx Med; 2022 May; 3(2):e32902. PubMed ID: 37725552
[TBL] [Abstract][Full Text] [Related]
23. Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system.
Jeong E; Nelson SD; Su Y; Malin B; Li L; Chen Y
Front Pharmacol; 2022; 13():938552. PubMed ID: 35935872
[No Abstract] [Full Text] [Related]
24. Potential drug-drug interactions of frequently prescribed medications in long COVID detected by two electronic databases.
Meakleartmongkol T; Tangpanithandee S; Vanavivit N; Jiso A; Pongchaikul P; Kirdlarp S; Khemawoot P; Nathisuwan S
PLoS One; 2023; 18(11):e0293866. PubMed ID: 37972000
[TBL] [Abstract][Full Text] [Related]
25. Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases.
S K SR; P A A; B S; Kalala KP; Pm A; Sabarathinam S
Diabetes Metab Syndr; 2022 Mar; 16(3):102451. PubMed ID: 35279008
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines.
Westergaard N; Tarnow L; Vermehren C
Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577599
[TBL] [Abstract][Full Text] [Related]
27. Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes.
Caspar SM; Schneider T; Meienberg J; Matyas G
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225115
[TBL] [Abstract][Full Text] [Related]
28. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
29. Genetic Epidemiology of Medication Safety and Efficacy Related Variants in the Central Han Chinese Population With Whole Genome Sequencing.
Tian J; Zhang J; Yang Z; Feng S; Li S; Ren S; Shi J; Hou X; Xue X; Yang B; Xu H; Guo J
Front Pharmacol; 2021; 12():790832. PubMed ID: 35280256
[TBL] [Abstract][Full Text] [Related]
30. Minimization of the Drug and Gene Interactions in Polypharmacy Therapies Augmented with COVID-19 Medications.
Lagumdzija-Kulenovic A; Kulenovic A
Stud Health Technol Inform; 2022 Jan; 289():114-117. PubMed ID: 35062105
[TBL] [Abstract][Full Text] [Related]
31. The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population.
Khan AR; Shah SH; Ajaz S; Firasat S; Abid A; Raza A
Evol Bioinform Online; 2022; 18():11769343221095834. PubMed ID: 35497687
[TBL] [Abstract][Full Text] [Related]
32. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015395. PubMed ID: 36126225
[TBL] [Abstract][Full Text] [Related]
33. Genetic Variation among Pharmacogenes in the Sardinian Population.
Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
[TBL] [Abstract][Full Text] [Related]
34. Drug-Drug-Gene Interactions in Cardiovascular Medicine.
Asiimwe IG; Pirmohamed M
Pharmgenomics Pers Med; 2022; 15():879-911. PubMed ID: 36353710
[TBL] [Abstract][Full Text] [Related]
35. Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations.
Li D; Xie AH; Liu Z; Li D; Ning B; Thakkar S; Tong W; Xu J
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33113799
[TBL] [Abstract][Full Text] [Related]
36. Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.
Barh D; Aljabali AA; Tambuwala MM; Tiwari S; Serrano-Aroca Á; Alzahrani KJ; Silva Andrade B; Azevedo V; Ganguly NK; Lundstrom K
Biomedicines; 2021 May; 9(5):. PubMed ID: 34067609
[TBL] [Abstract][Full Text] [Related]
37. Polymorphic analysis of CYP2C9 gene in Vietnamese population.
Vu NP; Ma TTH; Tran NTB; Huynh HTT; Nguyen TD; Nguyen DT; Van Nong H; Lee MTM; Nguyen HH
Mol Biol Rep; 2018 Oct; 45(5):893-900. PubMed ID: 29978384
[TBL] [Abstract][Full Text] [Related]
38. Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality.
Al-Taie A; Büyük AŞ; Sardas S
Pulm Pharmacol Ther; 2022 Dec; 77():102172. PubMed ID: 36265833
[TBL] [Abstract][Full Text] [Related]
39. High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment.
Macías J; Pinilla A; Lao-Dominguez FA; Corma A; Contreras-Macias E; González-Serna A; Gutierrez-Pizarraya A; Fernández-Fuertes M; Morillo-Verdugo R; Trigo M; Real LM; Pineda JA
Sci Rep; 2020 Dec; 10(1):20958. PubMed ID: 33262433
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results.
Schmidlen T; Sturm AC; Scheinfeldt LB
J Pers Med; 2020 Apr; 10(2):. PubMed ID: 32340147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
